Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Br J Anaesth ; 119(6): 1127-1134, 2017 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-29136086

RESUMEN

Background: The threshold of intraoperative urine output below which the risk of acute kidney injury (AKI) increases is unclear. The aim of this retrospective cohort study was to investigate the relationship between intraoperative urine output during major abdominal surgery and the development of postoperative AKI and to identify an optimal threshold for predicting the differential risk of AKI. Methods: Perioperative data were collected retrospectively on 3560 patients undergoing major abdominal surgery (liver, colorectal, gastric, pancreatic, or oesophageal resection) at Kyoto University Hospital. We evaluated the relationship between intraoperative urine output and the development of postoperative AKI as defined by recent guidelines. Logistic regression analysis was performed to adjust for patient and operative variables, and the minimum P -value approach was used to determine the threshold of intraoperative urine output that independently altered the risk of AKI. Results: The overall incidence of AKI in the study population was 6.3%. Using the minimum P -value approach, a threshold of 0.3 ml kg -1 h -1 was identified, below which there was an increased risk of AKI (adjusted odds ratio, 2.65; 95% confidence interval, 1.77-3.97; P <0.001). The addition of oliguria <0.3 ml kg -1 h -1 to a model with conventional risk factors significantly improved risk stratification for AKI (net reclassification improvement, 0.159; 95% confidence interval, 0.049-0.270; P =0.005). Conclusions: Among patients undergoing major abdominal surgery, intraoperative oliguria <0.3 ml kg -1 h -1 was significantly associated with increased risk of postoperative AKI.


Asunto(s)
Abdomen/cirugía , Lesión Renal Aguda/diagnóstico , Complicaciones Intraoperatorias/orina , Oliguria/orina , Complicaciones Posoperatorias/diagnóstico , Lesión Renal Aguda/orina , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/orina , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
3.
Acta Anaesthesiol Scand ; 61(9): 1075-1083, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28748536

RESUMEN

BACKGROUND: Acute kidney injury (AKI) is a common complication with a major impact on morbidity and mortality after cardiac surgery with cardiopulmonary bypass (CPB). The aim of the present study was to perform a detailed analysis on the release of the tubular injury biomarker N-acetyl-b-D-glucosaminidase (NAG) during and early after CPB and to describe independent predictors of maximal tubular injury. We hypothesized that renal tubular injury occurs early after the onset of CPB. METHODS: In this prospective observational study, we included 61 patients undergoing open cardiac surgery with an expected CPB duration exceeding 60 min. The urinary NAG levels were measured at 30 min intervals during CPB, as well as early (30 min) after CPB and post-operatively. Independent predictors of tubular injury were identified using an Interquantile multivariate regression model. RESULTS: Already 30 min after the onset of CPB, NAG excretion was significantly increased (P < 0.001), followed by a sixfold peak increase after discontinuation of CPB (P < 0.001). In the multivariable regression model, CPB duration (P < 0.05) and the degree of rewarming during CPB (P < 0.05), were independent predictors of peak NAG excretion. CONCLUSION: In cardiac surgery, a renal tubular cell injury is seen early after onset of CPB with a peak biomarker increase early after end of CPB. The magnitude of this tubular injury is independently related to CPB duration and the degree of rewarming. Efforts made to decrease the CPB duration and to avoid hypothermia and the need for rewarming may decrease the risk for tubular injury.


Asunto(s)
Acetilglucosaminidasa/orina , Lesión Renal Aguda/orina , Puente Cardiopulmonar/efectos adversos , Complicaciones Intraoperatorias/orina , Túbulos Renales/fisiopatología , Lesión Renal Aguda/etiología , Lesión Renal Aguda/fisiopatología , Anciano , Anciano de 80 o más Años , Biomarcadores/orina , Análisis de los Gases de la Sangre , Femenino , Hemodinámica , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Recalentamiento , Factores de Riesgo
4.
PLoS One ; 8(4): e62245, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23630629

RESUMEN

MicroRNA-1 (miR-1) is a cardio-specific/enriched microRNA. Our recent studies have revealed that serum and urine miR-1 could be a novel sensitive biomarker for acute myocardial infarction. Open-heart surgeries with cardiopulmonary bypass (CPB) are often accompanied with surgery injury and CPB-associated injury on the hearts. However, the association of miR-1 and these intra-operative and post-operative cardiac injures is unknown. The objective of this study was to test the hypothesis that urine and serum miR-1 might be a novel biomarker for myocardial injuries in open-heart surgeries with CPB. Serum and urine miR-1 levels in 20 patients with elective mitral valve surgery were measured at pre-surgery, pre-CPB, 60 min post-CBP, and 24h post-CBP. Serum cardiac troponin-I (cTnI) was used as a positive control biomarker for cardiac injury. Compared with these in pre-operative and pre-CPB groups, the levels of miR-1 in serum and urine from patients after open-heart surgeries and CPB were significant increased at all observed time points. A similar pattern of serum cTnI levels and their strong positive correlation with miR-1 levels were identified in these patients. The results suggest that serum and urine miR-1 may be a novel sensitive biomarker for myocardial injury in open-heart surgeries with CPB.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/efectos adversos , Puente Cardiopulmonar/efectos adversos , Complicaciones Intraoperatorias/orina , MicroARNs/orina , Adulto , Biomarcadores/sangre , Biomarcadores/orina , Femenino , Humanos , Complicaciones Intraoperatorias/sangre , Complicaciones Intraoperatorias/etiología , Masculino , MicroARNs/sangre , Persona de Mediana Edad , Válvula Mitral/cirugía , Miocardio/patología , Troponina I/sangre
5.
J Endovasc Ther ; 13(5): 660-6, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17042662

RESUMEN

PURPOSE: To examine if N-acetylcysteine (NAC) reduces the incidence of contrast nephropathy during endovascular abdominal aortic aneurysm repair (EVAR) as evidenced by changes in markers of renal function. METHODS: Twenty consecutive men (mean age 72 years, range 65-79) undergoing EVAR were randomized to receive standard intravenous fluid hydration or standard fluid hydration and NAC (600 mg BID orally, 4 doses). Venous blood and urine were collected prior to the procedure and for 5 postoperative days and analyzed blindly for serum creatinine, urinary retinol-binding protein (RBP), and albumin/creatinine ratio (ACR). RESULTS: There were no significant differences in baseline demographics between the groups. No patient developed acute renal failure. In both groups, urinary RBP rose significantly from baseline (median 15 microg/mmol to peak 699 microg/mmol in controls versus 17 to 648 microg/mmol in the treatment group, p<0.003). There were similar significant rises in ACR (p<0.02). There was, however, no significant difference in the postoperative RBP or ACR between the groups at any time point. CONCLUSION: EVAR causes significant acute renal injury in most patients. This was not attenuated by N-acetylcysteine. The causes of renal injury are probably multifactorial, the long-term clinical significance of which is unclear.


Asunto(s)
Acetilcisteína/uso terapéutico , Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/prevención & control , Aneurisma de la Aorta Abdominal/cirugía , Medios de Contraste/efectos adversos , Depuradores de Radicales Libres/uso terapéutico , Procedimientos Quirúrgicos Vasculares , Lesión Renal Aguda/sangre , Lesión Renal Aguda/orina , Anciano , Aneurisma de la Aorta Abdominal/sangre , Aneurisma de la Aorta Abdominal/orina , Biomarcadores/sangre , Biomarcadores/orina , Creatinina/sangre , Humanos , Complicaciones Intraoperatorias/sangre , Complicaciones Intraoperatorias/inducido químicamente , Complicaciones Intraoperatorias/prevención & control , Complicaciones Intraoperatorias/orina , Masculino , Proyectos Piloto , Estudios Prospectivos , Proyectos de Investigación , Proteínas de Unión al Retinol/orina , Albúmina Sérica/metabolismo , Stents , Factores de Tiempo , Insuficiencia del Tratamiento , Procedimientos Quirúrgicos Vasculares/instrumentación
6.
J Neurosurg Anesthesiol ; 7(4): 259-62, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8563446

RESUMEN

We describe a case of propylene glycol toxicity due to intravenous administration of etomidate for cerebral protection. A continuous etomidate infusion was titrated to burst suppression of the electroencephalogram during surgical resection of a large intracranial arteriovenous malformation. The etomidate formulation used (Amidate, Abbot) contains etomidate 2 mg/ml in a 35% propylene glycol vehicle. A total of 5 g/kg of the solvent was given during 12 h. Adverse effects of propylene glycol were observed including hyperosmolality with an increased osmolal gap, hemolysis, hemoglobinuria, and metabolic acidosis. Normalization of these metabolic and ionic alterations occurred after 12 h of discontinuation of the infusion. The potential toxicity of the solvent should be considered during long-term administration of etomidate.


Asunto(s)
Anestésicos Intravenosos/efectos adversos , Etomidato/efectos adversos , Complicaciones Intraoperatorias/inducido químicamente , Glicoles de Propileno/efectos adversos , Acidosis/sangre , Anestésicos Intravenosos/administración & dosificación , Angiografía , Análisis de los Gases de la Sangre , Niño , Electroencefalografía/efectos de los fármacos , Etomidato/administración & dosificación , Hemodinámica/efectos de los fármacos , Hemoglobinuria/inducido químicamente , Humanos , Infusiones Intravenosas , Malformaciones Arteriovenosas Intracraneales/cirugía , Complicaciones Intraoperatorias/orina , Masculino , Solventes/efectos adversos
7.
Minerva Anestesiol ; 56(4): 101-4, 1990 Apr.
Artículo en Italiano | MEDLINE | ID: mdl-2215990

RESUMEN

In 8 patients who underwent abdominal surgery for non-neoplastic reasons, we have evaluated some parameters of renal function (PRP, NaU, GFR and diuresis) plasma levels of PRA and ADH and urinary prostaglandins PGE2 and 6-keto-PGF1 alpha. In 4 patients we found that surgery per se was associated with enhancements of PRA, ADH and 6-keto-PGF1 alpha. In other 4 patients, Indomethacin, a specific inhibitor of prostaglandin synthesis was given and this was followed by impairment of natriuresis and RPF. These data confirm the central role of prostaglandins in the control of diuresis and natriuresis and suggest that use of drugs affecting prostaglandin synthesis should be avoided in patients who are undergoing surgery.


Asunto(s)
Diuresis , Complicaciones Intraoperatorias/fisiopatología , Prostaglandinas/orina , Adulto , Humanos , Complicaciones Intraoperatorias/orina , Persona de Mediana Edad
8.
Nihon Geka Gakkai Zasshi ; 86(6): 657-68, 1985 Jun.
Artículo en Japonés | MEDLINE | ID: mdl-4033621

RESUMEN

Urinary N-acetyl-beta-D-glucosaminidase (U-NAG) activities were measured in 62 patients surgically treated in our clinic. The results obtained were as follows: The preoperative U-NAG activities were 9.53 +/- 8.63 IU/day in patients in elective operations, and 31.39 +/- 23.47 IU/day in cases in emergency surgery or exploratory laparotomies. The U-NAG activities were elevated slightly even in patients with no postoperative complications, suggesting there was significant damage to the renal tubular epithelium. In the patients with postoperative complications, the U-NAG activities were elevated markedly, especially in those with circulatory shock, suggesting severe damage to the renal tubular epithelium. Though the U-NAG showed abnormally high activities, the values of BUN, S-Cr, U-protein, UUN/BUN, FENa, Ccr, CH2O remained within the normal range. On the contrary, when they were abnormal, the U-NAG activities were not elevated. All patients, who showed high U-NAG activities with abnormal values of Ccr and/or CH2O, developed acute renal failure (ARF). In order to detect ARF in an early stage, Ccr and CH2O should be measured when U-NAG activities rose to over 50 IU/day.


Asunto(s)
Acetilglucosaminidasa/orina , Hexosaminidasas/orina , Riñón/fisiopatología , Procedimientos Quirúrgicos Operativos , Acetilglucosaminidasa/metabolismo , Adolescente , Adulto , Anciano , Nitrógeno de la Urea Sanguínea , Creatinina/orina , Enfermedades del Sistema Digestivo/orina , Epitelio/fisiopatología , Femenino , Cardiopatías/orina , Humanos , Complicaciones Intraoperatorias/orina , Túbulos Renales/fisiopatología , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/orina , Proteinuria/orina , Trastornos Respiratorios/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...